Boston Scientific Corp (BSX)vsHeart Test Laboratories Inc. Common Stock (HSCS)
BSX
Boston Scientific Corp
$45.98
-0.09%
HEALTHCARE · Cap: $63.87B
HSCS
Heart Test Laboratories Inc. Common Stock
$2.08
-3.70%
HEALTHCARE · Cap: $7.86M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 477286332% more annual revenue ($20.61B vs $4,319). BSX leads profitability with a 17.3% profit margin vs 0.0%. BSX earns a higher WallStSmart Score of 76/100 (B+).
BSX
Strong Buy76
out of 100
Grade: B+
HSCS
Avoid13
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-23.2%
Fair Value
$37.36
Current Price
$45.98
$8.62 premium
Intrinsic value data unavailable for HSCS.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Strong operational efficiency at 20.6%
Reasonable price relative to book value
Areas to Watch
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.
Bull Case : HSCS
The strongest argument for HSCS centers on Price/Book.
Bear Case : BSX
The primary concerns for BSX are Altman Z-Score.
Bear Case : HSCS
The primary concerns for HSCS are EPS Growth, Market Cap, Profit Margin. Debt-to-equity of 17.41 is elevated, increasing financial risk.
Key Dynamics to Monitor
BSX profiles as a mature stock while HSCS is a value play — different risk/reward profiles.
HSCS carries more volatility with a beta of 1.79 — expect wider price swings.
BSX is growing revenue faster at 11.6% — sustainability is the question.
BSX generates stronger free cash flow (171M), providing more financial flexibility.
Bottom Line
BSX scores higher overall (76/100 vs 13/100), backed by strong 17.3% margins and 11.6% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Heart Test Laboratories Inc. Common Stock
HEALTHCARE · MEDICAL DEVICES · USA
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company is headquartered in Southlake, Texas.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?